Steady Remission of Scleromyxedema 3 Years After Autologous Stem Cell Transplantation: An in Vivo and in Vitro Study

Blood. 2006 Jul 15;108(2):773-4. doi: 10.1182/blood-2006-01-0186.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Connective Tissue Diseases / therapy
  • Disease-Free Survival
  • Fibroblasts / chemistry
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Male
  • Myxedema / therapy*
  • Proteins / analysis
  • Remission Induction
  • Transplantation, Autologous

Substances

  • Proteins